Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lipocine (LPCN) Long-Term Investments (2021)

Lipocine (LPCN) has disclosed Long-Term Investments for 1 consecutive years, with $2.0 million as the latest value for Q4 2021.

  • For the quarter ending Q4 2021, Long-Term Investments changed N/A year-over-year to $2.0 million, compared with a TTM value of $2.0 million through Dec 2021, changed N/A, and an annual FY2021 reading of $2.0 million, changed N/A over the prior year.
  • Long-Term Investments was $2.0 million for Q4 2021 at Lipocine, down from $4.6 million in the prior quarter.
  • Across five years, Long-Term Investments topped out at $4.6 million in Q1 2021 and bottomed at $2.0 million in Q4 2021.